1. Introduction {#sec1}
===============

*Entamoeba histolytica* is the enteric protozoan parasite responsible for human amoebiasis that affects 50 million people around the world, causing colitis and liver abscesses \[[@B1]\]. In this organism, phagocytosis and vesicular trafficking play a critical role in ingestion and degradation of host cells and microorganisms. Vacuolar protein sorting (Vps) factors and some proteins that participate in vesicle transport in eukaryotes have been identified in *E. histolytica* \[[@B2]--[@B4]\].

In eukaryotic cells, endocytosis consists in phagocytosis, micropinocytosis and pinocytosis. Particularly, phagocytosis involves the ingestion of particles of varying size into phagosomes, which sequentially fuse with early and late endosomes forming multivesicular bodies (MVB), as well as with lysosomes to form phagolysosomes \[[@B5]\]. Additionally, MVB are critical for cell receptors down-regulation, retroviral budding and other processes \[[@B6]--[@B8]\]. MVB formation is driven by the assembly of endosomal sorting complexes required for transport (ESCRT), which result from the interaction of different class E Vps proteins \[[@B9], [@B10]\].

The MVB-sorting process initiates with the association of Vps27 and Hse1 proteins to form the ESCRT-0 complex, which is targeted to endosomal membrane domains that bind ubiquitinated cargo proteins (reviewed in \[[@B6], [@B7]\]). Then, ESCRT-0 recruits ESCRT-I formed by Vps23, Vps28, and Vps37 proteins, as well as an additional subunit called Mvb12 \[[@B11], [@B12]\]. Later, ESCRT-II, composed by Vps22, Vps25, and Vps36 proteins, is activated by ESCRT-I \[[@B13]\]. Ubiquitinated cargo proteins are recognized by ESCRT-I via Vps23 and by ESCRT-II via Vps36. Then, ESCRT-III, formed by Vps20, Vps32, Vps2, and Vps24, interacts with ESCRT-II components to complete ESCRT formation \[[@B14]\]. ESCRT-III is required for cargo molecules concentration into MVB vesicles and it coordinates the association of Bro1 protein and Doa4-deubiquitinating enzyme \[[@B15]--[@B17]\]. Finally, Vps4 protein catalyzes the ATP-dependent dissociation of ESCRT complexes from endosomes to initiate new rounds of vesicle formation and cargo molecules transport \[[@B6], [@B7]\]. Particularly, it has been reported that substitution of the conserved E amino acid residue by a Q residue in the Vps4 ATPase motif impairs ATP hydrolysis activity \[[@B18], [@B19]\], resulting in an inefficient protein transport from endosomal compartments to vacuoles or lysosomes \[[@B20]--[@B22]\], which evidenced the critical role of Vps4 in protein transport and vesicle trafficking.

In *E. histolytica*, experimental evidence suggests that MVB-like structures are formed by fusion of inward budding membranes with phagosomes \[[@B23]\]. Ubiquitin, deubiquitinating enzymes and a SNF7 homologue (vesicular trafficking protein) have been identified in isolated phagosomes by proteomic analysis, suggesting that a mechanism similar to MVB formation could be present in *E. histolytica*\[[@B23]--[@B25]\]. Additionally, the Bro1 domain-containing EhADH112 protein, which forms part of the *E. histolytica* EhCPADH complex involved in parasite virulence, is located in MVB-like structures in trophozoites \[[@B26], [@B27]\]. However, molecular mechanisms regulating MVB formation in *E. histolytica* remain poorly understood. Here, by *in silico* analysis from parasite genome databases, we identified 20 ESCRT protein-encoding genes in *E. histolytica* and showed that most of them were transcribed in trophozoites. Since Vps4 has been described as a key molecule to complete the disassembly of ESCRT and associated factors in other systems, we initiated the study of ESCRT machinery in *E. histolytica* by cloning and characterizing the EhVps4 protein. Biochemical assays showed that EhVps4 exhibits ATPase activity in vitro. Interestingly, by using trophozoites overexpressing the wild type and a mutant version of EhVps4, we provide data supporting a role for this protein in phagocytosis and virulence.

2. Material and Methods {#sec2}
=======================

2.1. In Silico Identification of Putative ESCRT Genes in E. histolytica {#sec2.1}
-----------------------------------------------------------------------

Sequence similarity searches for ESCRT genes were performed in *E. histolytica* genome database (<http://pathema.jcvi.org/cgi-bin/Entamoeba/PathemaHomePage.cgi>) by BLAST using human and yeast ESCRT protein sequences as queries. Putative *E. histolytica* ESCRT homologous proteins were selected using the following criteria: (i) at least 20% identity and 35% similarity to the query sequence; (ii) *e*-value lower than 0.002; and (iii) absence of stop codons in the coding sequence. Predicted amino acids sequences were aligned by ClustalW software (<http://www.ebi.ac.uk/clustalw/>). Functional and structural domains were predicted using PROSITE ([http://www.expasy.org/tools/scanPROSITE/](http://www.expasy.org/tools/scanprosite/)) and Pfam (<http://www.sanger.ac.uk/Software/Pfam/>) databases. Phylogenetic relationships among putative ESCRT proteins from *E. histolytica* and other organisms were analyzed using the Neighbor-Joining distance method \[[@B28]\] as implemented in the MEGA package version 3.1 \[[@B29]\]. Phylogenetic trees were generated for each putative*E. histolytica* ESCRT protein aligned with homologues from different species. Robustness of phylogenetic inferences was tested by bootstrapping method, involving 1000 replications of the data based on the criteria of 50% majority-rule consensus.

For 3D modeling of MIT and AAA domains of *E. histolytica* EhVps4, predicted tertiary structures were obtained with the Phyre server (<http://www.sbg.bio.ic.ac.uk/phyre/>), using crystal data from yeast Vps4 MIT (2v6xA) and AAA (2qpaB) domains as templates.

2.2. E. histolytica Cultures {#sec2.2}
----------------------------

Trophozoites of *E. histolytica* clone A (strain HM1: IMSS) were axenically cultured in TYI-S-33 medium at 37°C and harvested during exponential growth phase \[[@B30]\]. Medium for transfected trophozoites was supplemented with 40 *μ*g/mL G418 (Gibco). Cell viability was monitored by microscopy using Trypan blue dye exclusion test.

2.3. Semi-Quantitative RT-PCR Assays {#sec2.3}
------------------------------------

Using Trizol reagent (Invitrogen), total RNA was extracted from 10^6^ trophozoites grown in TYI-S-33 medium or 5 minutes after red blood cells (RBC) ingestion.Semiquantitave RT-PCR was performed using 1 *μ*g of DNAse I-treated total RNA that was reverse transcribed using Superscript II (Invitrogen) for 2 hours at 42°C. Control samples without Superscript-II were included in all experiments. cDNA samples were subjected to PCR amplification using specific internal primers for distinct *E. histolytica*putative ESCRT genes(see Table T1 in Supplementary material available on line at doi: 10.1155/2010/890674).Briefly, PCR consisted in an initial denaturation step at 94°C for 5 minutes followed by 25 cycles of 35 s at 94°C, 30 s at Tm calculated for each gene(Supplementary data Table T1),1 minute 30 s at 72°C and a final extension step at 72°C for 7 minutes. As a control, we amplified a *Eh25S rRNA* gene internal sequence which was used to normalize densitometric data. Products were separated by 1% agarose gel electrophoresis, stained with ethidium bromide and visualized by UV light in a Gel Doc 1000 apparatus (BioRad). Densitometric analysis was performed using the Quantity One software. Three independent experiments were done by duplicate. Statistical significance was determined by *T* Student test \[[@B31]\].

2.4. Cloning and Sequencing of Ehvps4 and Ehvps4-E211Q Genes {#sec2.4}
------------------------------------------------------------

The full-length *Ehvps4* gene (1260 bp) reported at locus EHI_118900 in *E. histolytica* Pathema database was PCR amplified from *E. histolytica* genomic DNA using the *Ehvps4*-forward (5′-CCCCCGGATCCATGACATCGTTACTTGATAAAGG-3′) and *Ehvps4*-reverse (5′-CCCCCCTCGAGTTATCCATCTTGTCCAAATTGTTC-3′) primers in the presence of 0.2 U Pfx DNA polymerase (Invitrogen). Briefly, PCR consisted in an initial denaturation step at 94°C for 5 minutes followed by 28 cycles (30 s at 94°C, 35 s at 55°C, and 1 minute 30 s at 72°C) and a final extension step at 72°C for 7 minutes. The PCR product was cloned into TOPO vector (Invitrogen) yielding the TOPO-*Ehvps4* plasmid. Using the QuikChange mutagenesis kit (Stratagene), we generated a point mutation in the EhVps4 ATPase domain at amino acid 211 to replace glutamic acid (E) by glutamine (Q) to obtain the TOPO *Ehvps4*-E211Q plasmid. Both constructions were confirmed by automated DNA sequencing. Then, *Ehvps4*and*Ehvps4*-E211Q genes were PCR amplified from TOPO plasmids and subcloned in the pGEX-6P1 expression vector (Amersham Biosciences) to generate the recombinant pGEX-6P1-*Ehvps4*and pGEX-6P1-*Ehvps4-*E211Q plasmids, respectively. Constructions were confirmed by automated DNA sequencing.

2.5. Expression and Purification of Recombinant EhVps4-GST and EhVps4-E211Q-GST Proteins {#sec2.5}
----------------------------------------------------------------------------------------

*Escherichia coli*BL21 (DE3) pLysS (Invitrogen) bacteria were transformed with pGEX-6P1*-Ehvps4* or pGEX-6P1-*Ehvps4*-E211Q plasmids to produce the GST-tagged rEhVps4 and rEhVps4E211Q proteins. Bacteria were grown at 37°C in 2-TY medium containing 100 *μ*g/mL ampicillin and 34 *μ*g/mL chloramphenicol. rEhVps4-GST expression was induced by 1 mM isopropyl beta-D-thiogalacto pyranoside (IPTG) for 3 hours at 37°C. Cells were harvested, resuspended in ice cold PBS buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na~2~HPO~4~, and 1.8 mM KH~2~PO~4~ pH 7.3) and lysed by sonication at 4°C in the presence of lisozyme (1 mg/mL). rEhVps4-GST and rEhVps4-E211Q-GST polypeptides were purified near to homogeneity through glutathione affinity chromatography, according to manufacturer recommendations (Amersham Biosciences). To further use the recombinant protein as antigen, the GST tag (25 kDa) was removed from rEhVps4-GST protein by incubation with 2 U PreScission Protease (Amersham Biosciences) during 12 hours at 4°C. Cleaved rEhVps4 protein was dialyzed into PBS pH 7.4. Identity and integrity of purified rEhVps4-GST, rEhVps4-E211Q-GST and rEhVps4 proteins were confirmed by 10% SDS-PAGE and Western blot assays using anti-GST, (GE-Healthcare, 1 : 5000 dilution) and anti-rEhVps4 (1 : 15000 dilution) antibodies, respectively, and the ECL-Plus Western blotting detection system (Amersham Biosciences).

2.6. Generation of Polyclonal Antibodies against EhVps4 {#sec2.6}
-------------------------------------------------------

Purified rEhVps4 without GST tag was submitted to preparative 10% SDS-PAGE and electroeluted from Coomassie stained gels. rEhVps4 (200 *μ*g) in complete Freund\'s adjuvant (Sigma) was subcutaneously inoculated into a New Zealand male rabbit, and then, three doses of 100 *μ*g rEhVps4 in incomplete Freund\'s adjuvant were injected at 15 days intervals. Rabbit was bled to obtain polyclonal serum.

2.7. ATPase Activity Assay {#sec2.7}
--------------------------

The ATPase activity assay procedure was based on that previously described \[[@B32]\] using the PiPer Phosphate Assay kit (Invitrogen), with minimal modifications. Briefly, Amplex red was diluted in DMSO to a 10 mM final concentration. Maltose phosphorylase, maltose, glucose oxidase, and horseradish peroxidase were diluted in enzyme buffer (0.1 M Tris-HCl, pH 7.5) to a final concentration of 200 U/mL, 40 mM, 200 U/mL, and 100 U/mL, respectively. Assay buffer (100 mM Tris, 20 mM KCl, and 6 mM MgCl~2~, pH 7.4) was added to a 96-well plate. The volume corresponding to 3.5 *μ*g and 5 *μ*g of purified and dialyzed rEhVps4-GST, rEhVps4-E211Q-GST, and rGST proteins was added to wells and enzyme buffer was added up to 27 *μ*L. 50 *μ*L of working solution (2 U/mL glucose oxidase, 4 U/mL maltose phosphorylase, 0.4 mM maltose, 100 *μ*M amplex red, 0.4 U/mL HRP) were added to wells. Controls consisting in enzyme buffer or enzyme buffer with working solution were included. Fresh ATP was diluted in assay buffer to a concentration of 2.5 mM and added to each well to a final volume of 100 *μ*L. Plates were mixed by pipetting and shacked for 30 s to ensure homogeneity. Then, reactions were kept at 25°C for 30 minutes and protected from the light. The absorbance was measured at 562 nm at 30 minutes and data were documented. The purified rGST protein was used as negative control in ATPase assays. Assays were performed twice by triplicate.

2.8. Plasmids Construction for Transfection Assays {#sec2.8}
--------------------------------------------------

The mutant *Ehvps4*-E211Q gene and the wild type *Ehvps4* gene were PCR amplified from TOPO *Ehvps4*-E211Q and TOPO-*Ehvps4*, respectively, using the *Ehvps4-S*-*Kpn*I (5′-CCCCCGGTACCATGACATCGTTACTTGATAAAGG-3′) and *Ehvps4-AS*-FLAG-*Bam*HI (5′-CCCCCGGATCCTTA[CTTATCGTCGTCATCCTTGTAATC]{.ul}TCCATCTTGTCCAAATTGTTC-3′) primers and cloned into p*NEO* vector for further transfection assays \[[@B33]\]. The underlined nucleotide sequence corresponds to the FLAG epitope (1 kDa) \[[@B34]\] that was added to the carboxy terminus of recombinant proteins to allow their specific immunodetection in transfected trophozoites. The resulting plasmids named p*EhVps4*-E211Q and p*EhVps4* were confirmed by automated DNA sequencing.

2.9. In Vitro and In Vivo Virulence of Transfected Cells {#sec2.9}
--------------------------------------------------------

Trophozoites were transfected with 200 *μ*g of p*EhVps4*-E211Q, p*EhVps4* and control p*NEO* plasmids by electroporation as described \[[@B33]\]. Briefly, amoebae (10^7^) were washed twice in cold PBS and once in cold complete cytomix buffer. Electroporation was performed with the Bio-Rad Gene Pulser using 1200 V/cm and 25 *μ*F, with a constant time of 0.4 ms. Electroporated cells were transferred into fresh culture medium for 48 hours before selecting them with 10 *μ*g/mL G418.

In vitro virulence of nontransfected and transfected trophozoites (10^5^) was measured on MDCK cells (6 × 10^4^) as described \[[@B35], [@B36]\]. Rate of erythrophagocytosis was evaluated using trophozoites and RBC in a 1 : 100 relation, at 5, 10, and 15 minutes \[[@B37]\].

In vivo virulence of transfected trophozoites was evaluated as described \[[@B38]\]. Briefly, under sterile conditions and intraperitoneal anaesthesia with 0.2 mg Anesthesal (Pfizer), three groups of six hamsters each were laparotomized and intraportally challenged with p*EhVps4*-E211Q, p*EhVps4,* or p*NEO* transfected trophozoites (2.5 × 10^6^) in a volume of 0.1 mL PBS using a 29-gauge needle. Seven days after challenge, animals were anaesthetized and livers were removed to evaluate hepatic damage.

2.10. Immunodetection of EhVps4 in Trophozoites {#sec2.10}
-----------------------------------------------

Western blot assays were performed using 30 *μ*g of total proteins from nontransfected or p*NEO*, p*EhVps4*, and p*EhVps4*-E211Q transfected trophozoites. We used anti-FLAG monoclonal (1 : 700) or anti-rEhVps4 polyclonal (1 : 15000) antibodies and rabbit anti-mouse and goat anti-rabbit IgG horseradish peroxidase-labeled secondary antibodies (Zymed; 1 : 10000), respectively. Immunodetected proteins were revealed with the ECL Plus Western blotting system (Amersham Biosciences). As an internal control, we used monoclonal antibodies raised against *E. histolytica* actin (1 : 1000) and goat anti-mouse IgG horseradish peroxidase-labeled secondary antibodies (Zymed; 1 : 10000).

For confocal microscopy assays, nontransfected and transfected trophozoites were grown on coverslips, fixed with 4% paraformaldehyde at 37°C for 1 hour, permeabilized with Triton X-100 and blocked with 1% bovine serum albumin in PBS. Then, nontransfected and transfected cells were incubated with polyclonal anti-rEhVps4 (1 : 5000) or monoclonal anti-FLAG primary antibodies (Sigma; 1 : 500), respectively, at 37°C for 2 hours, followed by incubation with anti-rabbit or anti-mouse fluoresceinated (Zymed; 1 : 100) monoclonal antibodies, at 37°C for 1 hour. Next, trophozoites were washed three times with PBS 1X at room temperature and DNA was counterstained with 4′, 6-diamidino-2-phenylindole (DAPI) (5 *μ*g/mL) for 5 minutes. To immunolocalize EhVps4 during erytrophagocytosis, p*EhVps4* transfected cells were incubated with RBC (1 : 20) for 10 minutes. Ingested RBC were stained with diaminobenzidine (0.84 mM 3,3′-diaminobenzidine, 0.048% H~2~O~2~ and 50 mM Tris-HCl, pH 9.5) for 5 minutes and cells were incubated with polyclonal anti-rEhVps4 (1 : 5000) to be processed for immunofluorescence as described above. Light optical sections (1.5 *μ*m) were obtained through a Leica inverted microscope attached to a laser confocal scanning system TCS-SP2 (Leica).

3. Results {#sec3}
==========

3.1. E. histolytica Genome Contains Homologous ESCRT Genes That Are Expressed in Trophozoites {#sec3.1}
---------------------------------------------------------------------------------------------

To investigate the presence of ESCRT-related genes in *E. histolytica*, we surveyed the parasite genome sequence at Pathema database using the amino acid sequences of yeast and human ESCRT proteins as queries. We detected a set of 20 putative ESCRT protein-encoding genes, which exhibited significant *e*-values (1.1*e* − 114 to 0.00032) and high similarity (20 to 62%) to yeast and human ESCRT (ESCRT 0-III and associated factors) orthologues (see [Table 1](#tab1){ref-type="table"}). However, we did not find homologues for yeast Mvb12, and Bul1p protein involved in protein ubiquitination, neither human Vps37-B and Vps37-C proteins. Phylogenetic inference revealed that *E. histolytica* ESCRT predicted proteins are closely related to homologous proteins from other protozoa, such as *Giardia lamblia*, *Tetrahymena thermophila*, *Trichomonas vaginalis*, *Plasmodium vivax*, *Cryptosporidium homini,* and *Trypanosoma cruzi*(data not shown). Bioinformatics analysis showed that *E. histolytica* ESCRT predicted proteins have the most characteristic functional domains (see Supplementary data Figure S1) and tertiary structure folding described for yeast and human ESCRT factors (data not shown).

To determine whether the putative *E. histolytica* ESCRT genes were expressed, we performed RT-PCR assays for the 16 most conserved genes. In basal culture conditions, 15 genes were transcribed, but the *Ehvps22*transcript was not detected in these experiments (see Figures [1(a)](#fig1){ref-type="fig"} and [1(b)](#fig1){ref-type="fig"}). We also performed RT-PCR assays using RNA obtained from trophozoites incubated with RBC for 5 minutes to investigate whether erythrophagocytosis has an effect on ESCRT gene expression (see Figures [1(a)](#fig1){ref-type="fig"} and [1(b)](#fig1){ref-type="fig"}). In these assays, we found that all genes were expressed during erythrophagocytosis at similar levels as in basal conditions. Again, we did not detect the *Ehvps22* gene expression. Interestingly, *Ehvps23* and*Ehadh112*were 2- and 3-fold up-regulated, respectively. By densitometric analysis, the band given by the amplified *Eh25S rRNA* product in both conditions was taken as 100% and used to normalize ESCRT genes data.

3.2. The Predicted EhVps4 Protein Conserves the Typical Architecture of Vps4 Homologues {#sec3.2}
---------------------------------------------------------------------------------------

Since Vps4 orthologues have been described as key molecules for the dissociation of ESCRT, we first focused on the characterization of the *E. histolytica*EhVps4 protein. The predicted EhVps4 contains the N-terminal MIT (microtubule interacting and transport), AAA (ATPase associated with a variety of activities) and Vps4 C-terminal domains (see [Figure 2(a)](#fig2){ref-type="fig"}) that are characteristic and essential for Vps4 proteins biological functions \[[@B39], [@B40]\]. Phylogenetic trees revealed that EhVps4 is more related to protozoan Vps4 than orthologous proteins from higher eukaryotes (see [Figure 2(b)](#fig2){ref-type="fig"}). Interestingly, 3D modeling of EhVps4, using the crystal structure of MIT and AAA domains from yeast Vps4p and human Vps4B as templates (see [Figure 2(c)](#fig2){ref-type="fig"}), showed that EhVps4 region spanning the N-terminal MIT and AAA ATPase domains exhibited a similar folding with the conserved Vps4 *α*-helices.

3.3. Expression and Immunodetection of EhVps4 Protein in Trophozoites {#sec3.3}
---------------------------------------------------------------------

We produced and purified the recombinant EhVps4 protein as a GST-tagged fusion polypeptide (rEhVps4-GST) in *E. coli* (see [Figure 3(a)](#fig3){ref-type="fig"}, lanes 3, 4). By Western blot assays using commercial anti-GST monoclonal antibodies, we immunodetected the purified rEhVps4-GST as a 72 kDa protein in IPTG-induced bacteria (see [Figure 3(b)](#fig3){ref-type="fig"}, lane 2) but not in protein extracts from noninduced bacteria (see [Figure 3(b)](#fig3){ref-type="fig"}, lane 1). The rEhVps4-GST was digested with the PreScission Protease to obtain the rEhVps4 untagged protein (47 kDa) (see [Figure 3(c)](#fig3){ref-type="fig"}, lanes 2 and 3), which was also purified (see [Figure 3(c)](#fig3){ref-type="fig"}, lane 4) and used to generate rabbit polyclonal antibodies. Anti-rEhVps4 serum recognized the untagged rEhVps4 protein, confirming the antibodies specificity (see [Figure 3(d)](#fig3){ref-type="fig"}). In addition, the same antibodies detected a single 47 kDa band in *E. histolytica*protein extracts (see [Figure 3(e)](#fig3){ref-type="fig"}, lane 1), which corresponds to the expected molecular weight for the predicted EhVps4 polypeptide amino acid sequence. Antibodies did not detect any other AAA ATPases predicted in the *E. histolytica* genome \[[@B41]\]. Pre-immune serum, used as a control, did not recognize any band in trophozoite extracts (see [Figure 3(e)](#fig3){ref-type="fig"}, lane 2). Through immunofluorescence and laser confocal microscopy assays, the specific rabbit polyclonal antibodies revealed EhVps4 as abundant small dots dispersed in the cytosol (see [Figure 3(f)](#fig3){ref-type="fig"}).

3.4. ATPase Activity Assays {#sec3.4}
---------------------------

To investigate whether the recombinant protein exhibited ATPase activity we used the rEhVps4 purified protein and a mutant version (EhVps4-E211Q) in which we changed the E211 residue of the AAA motif, essential for enzyme activity, by a Q residue (see [Figure 4(a)](#fig4){ref-type="fig"}) \[[@B18], [@B42]\]. Reactions were carried out using the PiPer Phosphate Assay Kit (Invitrogen) in the presence of 500 *μ*M ATP. Inorganic phosphate (Pi) release was measured spectrophotometrically at A~562~. At zero time, absorbance values of samples containing rEhVps4-GST, rEhVps4-E211Q-GST and control rGST purified proteins (see [Figure 4(b)](#fig4){ref-type="fig"}) were similar and they were taken as background. At 30 minutes, A~562~ values increased to 0.115 ± 0.008 and 0.162 ± 0.022, using 3.5 *μ*g and 5 *μ*g of rEhVps4-GST protein, respectively. No significant A~562~ increase was detected when we used rEhVps4-E211Q-GST or rGST proteins at 30 minutes (see [Figure 4(c)](#fig4){ref-type="fig"}). These results showed that rEhVps4-GST has ATPase activity and that the AAA motif is essential for ATP hydrolysis.

3.5. Generation of Trophozoites Overexpressing the EhVps4-FLAG and Mutant EhVps4-E211Q-FLAG Proteins {#sec3.5}
----------------------------------------------------------------------------------------------------

To investigate the role of EhVps4 in *E. histolytica*, we generated transfectant trophozoites that overexpress the EhVps4 and the mutant EhVps4-E211Q FLAG-tagged proteins (see [Figure 5(a)](#fig5){ref-type="fig"}). Trophozoites transfected with p*NEO* vector were used as control in these experiments. Viability of transfected trophozoites was up to 90% as determined by trypan blue exclusion assays.

RT-PCR assays, using specific primers for *Ehvps4* gene, showed that trophozoites transfected with p*EhVps4* or p*EhVps4*-E211Q plasmids expressed a higher amount of the *Ehvps4* transcript in comparison to p*NEO* transfected cells (see [Figure 5(b)](#fig5){ref-type="fig"}, upper panel, lanes 1, 2, and 3). As control, we amplified the *Eh25S rRNA* transcript, which showed minimal changes among the different transfectants studied (see [Figure 5(b)](#fig5){ref-type="fig"}, lower panel).

By Western blot assays, using the anti-FLAG antibodies, we detected the EhVps4-FLAG and EhVps4-E211Q-FLAG proteins in p*EhVps4* and p*EhVps4*-E211Q transfectant cells, whereas no signal was detected in p*NEO* transfectantes, as expected (see [Figure 5(c)](#fig5){ref-type="fig"}, upper panel). However, specific anti-rEhVps4 antibodies recognized endogenous EhVps4 protein in p*NEO* transfectants (see [Figure 5(c)](#fig5){ref-type="fig"}, middle panel, lane 1), meanwhile signal increased 2.8- and 9.2-fold in p*EhVps4* and p*EhVps4*-E211Q transfected cells, respectively (see [Figure 5(c)](#fig5){ref-type="fig"}, middle panel, lanes 2, and 3). Anti-actin antibodies detected similar amounts of protein in the different transfectants (see [Figure 5(c)](#fig5){ref-type="fig"}, lower panel). For densitometric analysis, actin band was taken as 100% in each lane and used to normalize EhVps4, EhVps4-FLAG, and EhVps4-E211Q-FLAG data (see [Figure 5(d)](#fig5){ref-type="fig"}).

3.6. Cellular Localization of EhVps4-FLAG and EhVps4-E211Q-FLAG Proteins in Transfected Trophozoites {#sec3.6}
----------------------------------------------------------------------------------------------------

To investigate the cellular localization of exogenous wild type EhVps4 and mutant EhVps4-E211Q FLAG-tagged proteins in transfected trophozoites, we performed immunofluorescence assays using anti-FLAG antibodies (see [Figure 6](#fig6){ref-type="fig"}). In p*EhVps4* transfected trophozoites, anti-FLAG antibodies detected the overexpressed exogenous protein diffuse in the cytoplasm and at the plasma membrane (see [Figure 6(d)](#fig6){ref-type="fig"}). In contrast, in mutant p*EhVps4*-E211Q transfected cells, signal was not observed at the plasma membrane, but it was present as cytoplasmic structures of varying sizes (see [Figure 6(f)](#fig6){ref-type="fig"}). As expected, no signal was detected by anti-FLAG antibodies in p*NEO* transfected cells (see [Figure 6(b)](#fig6){ref-type="fig"}). Control assays without anti-FLAG primary antibodies did not show any signal in transfected trophozoites (see [Figure 6(h)](#fig6){ref-type="fig"}).

3.7. Cytopathic Activity, Erythrophagocytosis and Liver Abscesses Formation Are Impaired in Trophozoites Overexpressing the Mutant EhVps4-E211Q-FLAG Protein {#sec3.7}
------------------------------------------------------------------------------------------------------------------------------------------------------------

To initiate the phenotypical characterization of trophozoites transfected with p*EhVps4* or p*EhVps4*-E211Q constructs, we first evaluated their cytopathic activity and rate of erythrophagocytosis. Nontransfected clone A and p*NEO* transfected cells were used as controls in these experiments. After 1 hour interaction of MDCK cells with trophozoites of clone A, p*NEO* or p*EhVps4*transfected trophozoites, monolayers presented in mean 86.8 ± 13.2% destruction. Interestingly, p*EhVps4-*E211Q transfected cells were less efficient to destroy MDCK cell monolayers, since they only produced 46.4 ± 6.4% cell destruction (see [Figure 7(a)](#fig7){ref-type="fig"}).

The rates of erythrophagocytosis of non-transfected clone A, p*NEO* and p*EhVps4* transfected cells were similar, at each time tested. In contrast, p*EhVps4*-E211Q transfected trophozoites showed 60, 55%, and 57% decrease in erythrophagocytosis rate at 5, 10, and 15 minutes, respectively, when compared with the mean rate from the other trophozoites (see [Figure 7(b)](#fig7){ref-type="fig"}).

Then, we investigated the capacity of p*EhVps4* and p*EhVps4*-E211Q transfected trophozoites to induce hepatic abscesses formation in hamsters. None of the six hamsters that were infected with p*EhVps4*-E211Q transfected trophozoites presented hepatic damage (see Figures [7(c)](#fig7){ref-type="fig"}), whereas the six animals infected with p*NEO* and p*EhVps4* transfected trophozoites developed extensive abscesses.

3.8. EhVps4 Was Detected around Ingested RBC {#sec3.8}
--------------------------------------------

To determine the localization of EhVps4 in p*EhVps4* transfected trophozoites during erythrophagocytosis, we performed immunofluorescence assays with anti-rEhVps4 serum. Antibodies detected EhVps4 as a signal surrounding ingested erythrocytes, suggesting that this protein may be involved in phagocytosis (see [Figure 8](#fig8){ref-type="fig"}).

4. Discussion {#sec4}
=============

In *E. histolytica* trophozoites, phagocytosis, and vesicular trafficking are important events for parasite nutrition and destruction of target cells. As in other eukaryotes, the endocytosis and phagocytosis pathways involve the formation of endosomes, MVB and lysosomes \[[@B5], [@B43]\]. Indeed, MVB*­*like structures have been detected in trophozoites \[[@B26], [@B27]\] and within isolated phagosomes \[[@B24]\], but proteins participating in their formation have not been identified.

Here, by mining the parasite genome sequence, we demonstrated the presence of 20 genes that encode putative ESCRT machinery components, which could participate in endosomal transport and MVB formation in *E. histolytica*. Most predicted proteins have the conserved functional domains and share high similarity and phylogenetic relationship with homologous proteins from other eukaryotes, strongly suggesting that they have similar functions. RT-PCR assays evidenced that 15 out of 16 ESCRT components tested are transcribed, which is consistent with the activity of endosome formation and vesicle trafficking exhibited by *E. histolytica* trophozoites (reviewed in \[[@B5], [@B43]\]). Except for the *Ehadh112* and *Ehvps23* genes, transcript amount was not significantly modified after 5 minutes of RBC interaction. Analysis of published *E. histolytica* microarrays data confirmed that most ESCRT genes are transcribed without any significant change under distinct experimental conditions \[[@B44], [@B45]\]. However, these experiments were not focused on phagocytosis. Additionally, in *Dictyostelium discoideum,* microarrays assays evidenced that expression of most genes involved in intracellular vesicle traffic is not significantly changed during phagocytosis \[[@B46]\]. In mouse macrophages, phagocytosis causes cellular redistribution of Hrs protein (the homologue of yeast Vps27p), but the protein amount remains unchanged \[[@B47]\]. It is possible that trophozoites could have enough ESCRT and associated proteins to perform erythrophagocytosis, if, as we think, these proteins are involved in phagocytosis in *E. histolytica*. However, changes in the gene expression of *E. histolytica* ESCRT members at shorter or larger times cannot be discarded.

In yeast and mammal cells, Vps4 is a key component for disassembly of ESCRT complexes from the endosomal membrane at the MVB invagination pathway \[[@B42], [@B48], [@B49]\]. We focused on EhVps4 protein to investigate its role in endocytosis, specifically in one of the "professional function" of *E. histolytica* trophozoites: phagocytosis. As in yeast, *E. histolytica* has only one *vps4* gene, while higher eukaryotes have two *vps4* genes \[[@B21], [@B50], [@B51]\]. By confocal microscopy, EhVps4 was immunodetected as abundant small dots dispersed in the cytosol. In yeast, mammals, plants, and the protozoan *Leishmania major,* similar structures have been identified as MVB formed during endocytosis and vesicular trafficking \[[@B22], [@B42], [@B51], [@B52]\].

Yeast Vps4p protein exhibits ATPase activity, which depends on the E233 residue present within the AAA domain \[[@B18], [@B42]\]. In this work, we showed that EhVps4 is an ATPase, which conserves the characteristic domains and folding of Vps4 homologues. This activity depends on the AAA domain since the mutant rEhVps4-E211Q-GST, in which E211 amino acid residue was substituted by Q residue, did not exhibit detectable ATP hydrolysis, as reported in yeast \[[@B18], [@B42]\].

We further investigated the biological relevance of EhVps4 by generating trophozoites that overexpress wild type EhVps4-FLAG and mutant EhVps4-E211Q-FLAG protein. As the endogenous protein, exogenous EhVps4-FLAG was located in abundant punctuate structures in the cytosol as reported in other organisms \[[@B42], [@B50], [@B52], [@B53]\]. However, overexpressed EhVps4-FLAG was also detected at plasma membrane. In transfected mammal cells that overexpress Sendai virus protein C and wild type Vps4, ALIX/AIP1 proteins are recruited at the plasma membrane to facilitate the budding of virus-like particles \[[@B54]\]. EhADH112, the *E. histolytica* homologue of ALIX, has been detected at the plasma membrane \[[@B55]\]. Experiments currently in progress will help us to define the role of Vps4 at the membrane of trophozoites.

Erythrophagocytosis and cytopathic activities were not improved in trophozoites overexpressing wild type EhVps4-FLAG, probably because other ESCRT proteins are limiting factors for cell destruction and RBC intake \[[@B42], [@B52], [@B56]\]. However, the dominant negative effect of mutant EhVps4-E211Q-FLAG protein in MDCK cells destruction, the rate of RBC intake, and liver abscesses formation in hamsters, suggest a role for EhVps4 in *E. histolytica* virulence properties. The localization of EhVps4-FLAG protein around ingested RBC strengthens this hypothesis.

In conclusion, we showed that *E. histolytica* has an ESCRT machinery, which is transcribed in trophozoites. Particularly, we presented evidence that the conserved EhVps4 is an ATPase that could participate in cytopathic activity and erythrophagocytosis, as well as in hepatic damage in hamster. Work currently in progress is focusing on the identification of cytoplasmic structures containing EhVps4, as well as its interaction with other components of the *E. histolytica* ESCRT machinery.
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*Schematic representation of ESCRT machinery in E. histolytica, human and yeast*. Most known domains described in homologous ESCRT proteins are depicted for *E. histolytica* factors. EhHse1, EhVps27, EhVps23, EhVps28, EhVps46 and EhRsp5 proteins that lack several consensus domains were considered as *bona fide* ESCRT components, since BLAST analysis showed that they share high identity with homologous human and yeast proteins (see Table 1). The scale is shown at the bottom.
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![mRNA expression profile of *E. histolytica* putative ESCRT machinery genes. (a) RT-PCR products obtained from 1 *μ*g of total RNA from trophozoites growing in TYI-S-33 medium (0 minute) or after 5 minutes of erythrophagocytosis. (b) Densitometric analysis of RT-PCR products in (a). Pixels corresponding to *Eh25S rRNA* amplified product were taken as 100% in each lane. Data represent the mean of three independent experiments performed by duplicate for each gene. Asterisk, genes whose transcription is significantly changed according to *T* Student test.](JBB2010-890674.001){#fig1}

![Comparison of EhVps4 with other Vps4 proteins. (a) Schematic representation of Vps4 proteins from human, yeast and*E. histolytica.*Conserved MIT, AAA, and Vps4 C-terminal (C) domains were predicted using PROSITE and Pfam programs. (b) Phylogenetic relationships between EhVps4 and homologous proteins from other organisms. The phylogenetic tree of Vps4 homologues was created with the MEGA 3.1 program using the Neighbor Joining algorithm based on ClustalW alignments of complete amino acids sequences. Numbers on tree nodes represent the bootstrap proportions (%) of 1000 replications. The UniProt KnowledgeBase database accession number for each protein is indicated before the organism. (c) Comparison of 3D structures of MIT and AAA domains from human (*Hs*), yeast (*Sc*) and *E. histolytica*(*Eh*) Vps4 homologues. 3D modeling of EhVps4 MIT and AAA domains was obtained using crystal data from yeast Vps4p MIT (2v6xA) and AAA (2qpaB) domains as template, respectively.](JBB2010-890674.002){#fig2}

![Expression and immunodetection of EhVps4. (a) Expression and purification of recombinant EhVps4-GST polypeptide. Proteins were separated through 10% SDS-PAGE and gels were stained with Coomassie blue. Lane 1, molecular weight markers; lane 2, noninduced bacteria extract; lane 3, IPTG-induced bacteria extract; lane 4, affinity purified rEhVps4-GST from IPTG-induced bacteria extract. (b) Immunodetection of rEhVps4-GST. Western blot assays were performed using noninduced bacteria extract (lane 1) and IPTG-induced bacteria extract (lane 2), with anti-GST antibodies. (c) PreScission Protease digestion of rEhVps4-GST revealed by Coomassie blue stained gels. Lane 1, molecular weight markers; lane 2, purified rEhVps4-GST protein; lane 3, rEhVps4-GST digested with PreScission Protease; lane 4, purified rEhVps4 protein. (d) Immunodetection of purified rEhVps4 protein by Western blot assays using specific anti-rEhVps4 antibodies (lane 1). (e) Immunodetection of EhVps4 in total extracts of trophozoites using specific anti-rEhVps4 antibodies (lane 1) and preimmune serum (lane 2). Proteins are indicated by arrowheads. (f) and (g) Cellular localization of EhVps4 in trophozoites. Trophozoites of clone A were incubated with rabbit anti-rEhVps4 (f) or preimmune (g) serum, treated with FITC-labeled secondary antibodies, counterstained with DAPI and analyzed through confocal laser microscopy. Left, cells observed in phase contrast; right, merge (trophozoites observed in the green (FITC) and blue (DAPI) channels). Arrowheads, EhVps4 signal in small cytoplasmic dots.](JBB2010-890674.003){#fig3}

![Measurement of ATPase activity of recombinant EhVps4. (a) Multiple sequence alignment of Vps4 AAA domain from *Homo sapiens* (HsVps4A and HsVps4B), *S. cerevisiae* (ScVps4p) and*E. histolytica* (EhVps4). Black boxes, identical amino acid (aa); grey boxes, conserved substitutions; open boxes, different aa. Numbers at the left are relative to the position of the initial methionine in each protein. Arrowhead indicates the position of the conserved E residue. (b) Purification of recombinant proteins. Proteins were expressed in *E. coli*, purified through affinity chromatography, separated through 10% SDS-PAGE and stained with Coomassie blue. Lane 1, rEhVps4-GST; lane 2, rEhVps4-E211Q-GST; lane 3, rGST; lane 4, purified fraction from noninduced bacteria extract. (c) ATPase assay. ATPase activity of rEhVps4-GST and rEhVps4-E211Q-GST was monitored as described in [Section 2.7](#sec2.7){ref-type="sec"}. rGST was included as control. Data are the mean of three independent assays.](JBB2010-890674.004){#fig4}

![Expression of exogenous EhVps4 in transfected trophozoites. (a) Schematic representation of p*EhVps4*-E211Q construct. Mutant *Ehvps4* gene was cloned into the *Kpn*I and *Bam*HI sites of p*NEO* vector, upstream the sequence coding for FLAG epitope. B, *Bam*HI site; K, *Kpn*I site. (b) 2% agarose gel with RT-PCR assays products. An internal fragment of the *Ehvps4* gene (upper panel) or the *Eh25S rRNA*gene (bottom panel) was RT-PCR amplified using 1 *μ*g of total RNA from trophozoites of clone A transfected with p*NEO* (lane 1), p*EhVps4* (lane 2) or p*EhVps4*-E211Q (lane 3) plasmid. (c) Western blot assays. Anti-FLAG (upper panel), anti-rEhVps4 (middle panel) and anti-actin (lower panel) antibodies were used to analyze protein lysates (30 *μ*g) from p*NEO* (lane 1), p*EhVps4* (lane 2) and p*EhVps4*-E211Q (lane 3) transfected cells. (d) Densitometric analysis of bands corresponding to actin and EhVps4 in (c). Pixels corresponding to actin control were taken as 100% in each lane and used to normalize EhVps4 data.](JBB2010-890674.005){#fig5}

![Cellular localization of exogenous EhVps4 in transfected trophozoites. Trophozoites transfected with p*NEO* ((a) and (b)), p*EhVps4* ((c) and (d)) and p*EhVps4*-E211Q ((e) and (f)) were incubated with mouse anti-FLAG antibodies, treated with FITC-labeled secondary antibodies, counterstained with DAPI and analyzed through confocal laser microscopy. p*EhVps4*-E211Q transfected trophozoites incubated with FITC-labeled secondary antibodies were used as control ((g) and (h)). (a), (c), (e) and (g) Cells observed in phase contrast; (b), (d), (f) and (h) Merge, trophozoites observed in the green (FITC) and blue (DAPI) channels. Arrowheads, EhVps4 signal in plasma membrane and cytoplasmic dots.](JBB2010-890674.006){#fig6}

![Virulence assays of transfected trophozoites. (a) Cytopathic activity. The destruction of MDCK cells monolayers by clone A trophozoites, p*NEO*, p*EhVps4*, or p*EhVps4-*E211Q transfected cells was determined as described \[[@B32], [@B33]\]. (b) Erythrophagocytosis. Rate of phagocytosis of clone A trophozoites, p*EhVps4*, p*EhVps4*-E211Q or p*NEO* transfected cells was evaluated at 5, 10, and 15 minutes \[[@B34]\]. Histograms show the mean count ± SD of three independent experiments by duplicate. (c) Hepatic damage in hamsters infected with transfected trophozoites. Three groups of six hamsters were infected with p*NEO*, p*EhVps4*, or p*EhVps4-*E211Q transfected trophozoites. After 7 days, animals were sacrificed and liver damage was recorded. Pictures were taken from the liver side where the abscesses appeared to be larger and are representative for each group. Upper panels, livers from hamsters infected with p*NEO* transfected trophozoites (control); middle panels, livers from hamsters infected with p*EhVps4* transfected trophozoites; lower panels, livers from hamsters infected with p*EhVps4*-E211Q transfected trophozoites. 6/6, 6/6 and 0/6 denote number of infected animals/number of inoculated animals.](JBB2010-890674.007){#fig7}

![Cellular localization of EhVps4 protein during erythrophagocytosis. Trophozoites transfected with p*EhVps4* were incubated with RBC, treated with diaminobenzidine, anti-rEhVps4 and FITC-labeled secondary antibodies, and analyzed through confocal laser microscopy. (a) Cells observed in phase contrast. (b) Trophozoites observed in the green (FITC) channel and phase contrast. (c) Magnification of diaminobenzidine stained RBC squared in (b). Arrowhead, EhVps4 signal around RBC. N, nuclei.](JBB2010-890674.008){#fig8}

###### 

Comparison of *Entamoeba* *histolytica*, *Homo* *sapiens*, and *Saccharomyces* *cerevisiae* ESCRT machineries.

  Entamoeba histolytica       Homo sapiens   Saccharomyces cerevisiae                                                                                                   
  --------------------------- -------------- -------------------------- -------- ------------- -------------- ----- -------- -------- ------------- ------------- ----- -----
  ESCRT-0 complex             EhHse1         EHI_091530                 STAM1    Q92783        9*e* − 08      72    50       Hse1p    P38753        2*e* − 10     70    62
  EhVps27                     EHI_117910     HRS                        O14964   ---           ---            ---   Vps27p   P40343   1*e* − 11     61            49    
                                                                                                                                                                        
  ESCRT-I complex             EhVps23        EHI_135460                 TSG101   Q99816        1.4*e* − 10    51    33       Vps23p   P25604        0.0052        31    25
  EhVps28                     EHI_108630     hVps28                     Q9UK41   ---           ---            ---   Vps28p   Q02767   0.00057       45            28    
  EhVps37A                    EHI_077870     hVps37A                    Q6NW27   0.00022       55             24    Vps37p   Q99176   0.00084       46            21    
  EhVps37D                    EHI_060400     hVps37D                    Q6P2C3   3.8*e* − 06   50             35    nd       ---      ---           ---           ---   
  nd                          ---            nd                         ---      ---           ---            ---   Mvb12    P42939   ---           ---           ---   
                                                                                                                                                                        
  ESCRT-II complex            EhVps22        EHI_131120                 EAP30    Q96H20        9*e* − 22      47    30       Vps22p   Q12483        3.4*e* − 15   48    25
  EhVps25                     EHI_137860     EAP20                      Q9BRG1   9*e* − 08     52             28    Vps25p   P47142   0.00038       46            19    
  EhVps36                     EHI_045320     EAP45                      Q86VN1   1.8*e* − 15   49             25    Vps36p   Q06696   1.1*e* − 09   48            26    
                                                                                                                                                                        
  ESCRT-III complex           EhVps2         EHI_194400                 CHMP2A   O43633        8.9*e* − 24    55    29       Vps2p    P36108        2*e* − 05     50    29
                                             CHMP2B                     Q9UQN3   7.9*e* − 16   48             25    ---      ---      ---           ---           ---   
  EhVps20                     EHI_066730     CHMP6                      Q96FZ7   ---           ---            ---   Vps20p   Q04272   0.00015       54            26    
  EhVps24                     EHI_048690     CHMP3                      Q9Y3E7   ---           ---            ---   Vps24p   P36095   2.2*e* − 05   48            22    
  EhVps32                     EHI_169820     CHMP4A                     Q9BY43   0.0012        48             24    Vps32p   P39929   2.5*e* − 12   48            25    
                                             CHMP4B                     Q9H444   9.6*e* − 07   43             20    nd       ---      ---           ---           ---   
                                             CHMP4C                     Q96CF2   1.4*e* − 06   43             20    nd       ---      ---           ---           ---   
                                                                                                                                                                        
  Vps4                        EhVps4         EHI_118900                 hVps4A   Q9UN37        1.1*e* − 114   69    52       Vps4p    P52917        3*e* − 114    78    60
                                             hVps4B                     O75351   3*e* − 114    78             60    ---      ---      ---           ---           ---   
                                                                                                                                                                        
  Other MVB proteins          EhVta1         EHI_010040                 hVta1    Q9NP79        2.8*e* − 05    44    23       Vta1p    Q06263        ---           ---   ---
  EhVps46                     EHI_093850     CHMP1A                     Q9HD42   ---           ---            ---   Vps46p   P69771   0.00032       48            18    
                                             CHMP1B                     Q7LBR1   ---           ---            ---   nd       ---      ---           ---           ---   
  EhVps60                     EHI_114790     CHMP5                      Q9NZZ3   5.6*e* − 15   45             28    Vps60p   Q03390   9*e* − 06     46            19    
  EhDoa4                      EHI_012290     UBP4                       Q13107   1*e* − 77     58             36    Doa4p    P32571   2*e* − 27     50            31    
  EhADH112                    EHI_181220     ALIX                       Q9UKL5   1*e* − 21     40             20    Rim20p   Q12033   2*e* − 12     38            21    
                                                                                                                    BRO1p    P48582   0.003         50            32    
                                                                                                                                                                        
  Ubiquitination components   nd             ---                        nd       ---           ---            ---   ---      Bul1p    P48524        ---           ---   ---
  EhRsp5                      EHI_011530     NEED4                      P46934   1.6*e* − 50   53             33    Rsp5p    P39940   7.8*e* − 57   57            36    

^a^Pathema Entamoeba Bioinformatics Resource Center. ^b^Swiss-Prot/TrEMBL databases. nd: not determined. ---: Denote nonsignificant similarity/identity and *e*-values. S: Similarity. I: Identity.
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